In memoriam: Cell biologist Dr. Woodring Wright made seminal discoveries on aging and cancer development: Newsroom - UT Southwestern, Dallas, TX

https://www.utsouthwestern.edu/newsroom/articles/year-2019/woodring-wright.html

Woodring Erik Wright, Professor Emeritus of Cell Biology, passionate educator, and scientific trailblazer in the fight against aging and cancer, died on Aug. 2. He was 70.

CPRIT awards $9.6 million for UTSW projects in cancer treatments, screening, and genetics research: August 2016 News Releases - UT Southwestern, Dallas, TX

https://www.utsouthwestern.edu/newsroom/articles/year-2016/cprit-grants.html

Six new cancer research projects involving treatment, prevention, outreach, and genetics recently received a total of $9.6 million in support from the Cancer Prevention and Research Institute of Texas (CPRIT).

UT Southwestern investigators report first analysis of pioneering kidney cancer radiation approach in clinical trial: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2021/kidney-cancer-radiation.html

A new approach using precisely targeted, high-dose radiation to treat invasive kidney cancer proves safe, based on a clinical trial by the UT Southwestern Harold C. Simmons Comprehensive Cancer Center’s kidney cancer program.

Intermediary Metabolism and Cancer, Work in Progress - Adult Core: Cyclotron and Radiochemistry Program – UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/research/cyclotron/adult-core/work-in-progress/inter-metab.html

Information regarding User Group E, Intermediary Metabolism and Cancer, for UT Southwestern's Cyclotron and Radiochemistry Program Adult Core.

Researchers determine structure of an enzyme complex that plays a vital role in cancer development: October 2015 News Releases - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2015/enzyme-complex-structure.html

Researchers at UT Southwestern Medical Center have deciphered the long-sought atomic structure of PRC2, an enzyme complex that plays a key role in the development of several types of cancer, in particular blood cancer.

Eminent biologist Chen to discuss innate immunity in fight against cancer and autoimmune disease: September 2016 Center Times - UT Southwestern, Dallas, TX

https://www.utsouthwestern.edu/newsroom/articles/year-2016/pls-chen.html

Eminent biologist Chen to discuss innate immunity in fight against cancer and autoimmune disease: September 2016 Center Times - UT Southwestern, Dallas, TX

Business school professor given new purpose after cancer care: Newsroom - UT Southwestern, Dallas, TX

https://www.utsouthwestern.edu/newsroom/articles/year-2019/new-purpose-after-cancer-care.html

Casper has a Ph.D. in organizational psychology and studies ways of improving the health and well-being of employees. She never could have foreseen having her own work-life balance put to the test by cancer.

UTSW researchers part of winning global team in Cancer Grand Challenges : Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2022/cancer-grand-challenges.html

UT Southwestern researchers Zhijian “James” Chen, Ph.D., and Sihan Wu, Ph.D., are part of a team that has been awarded a Cancer Grand Challenges grant, a unique award that aims to solve some of cancer’s toughest problems by bringing together global teams with diverse areas of expertise.

The Cancer Answer Line answers your cancer questions | Cancer | UT Southwestern Medical Center

https://utswmed.org/medblog/cancer-answer-line-blog/

Welcome to the Cancer Answer Line blog. Physicians at UT Southwestern’s Harold C. Simmons Comprehensive Cancer Center in the Dallas/Fort Worth area will publicly answer questions about cancer and write about cancer-related topics.

Gastrointestinal Cancer Treatment | Gastrointestinal Cancer | UT Southwestern Medical Center

https://utswmed.org/conditions-treatments/gastrointestinal-cancer/gastrointestinal-cancer-treatment/

UT Southwestern GI cancer experts subspecialize in the treatment of gastrointestinal cancer patients using all the latest therapies.